At one month, ticagrelor was not superior to twice-daily clopidogrel in reducing major adverse cardiovascular events (MACEs) ...
Jacksonville, FL - A 150-mg maintenance dose of clopidogrel may be more appropriate than the standard 75-mg dose for patients with type 2 diabetes who are at higher risk of cardiovascular events than ...
DALLAS, TX — Long-term ischemic and bleeding risks climb with advancing age in elderly patients medically managed for acute coronary syndromes (ACS), as might be expected, but adding low-dose ...
Guidelines based on study showing BRILINTA reduces risk of cardiovascular events over clopidogrel in patients with Acute Coronary Syndrome WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) ...
ORLANDO, FL—Patients with coronary artery disease who need to switch from ticagrelor to clopidogrel after PCI should receive a loading dose of 600 mg clopidogrel between 12 and 24 hours following ...
ORLANDO — Higher doses of clopidogrel, up to 300 mg daily, were more effective than standard doses in patients with the CYP2C19 gene variant, according to late-breaking research from the ELEVATE-TIMI ...
A single lot of 75-mg clopidogrel tablets that was distributed nationwide is being recalled by the manufacturer due to mislabeling. International Laboratories, LLC voluntarily initiated the recall ...
Investigational compound reduces risk of major cardiovascular events by 19 percent, significantly improves net clinical benefit despite increased bleeding TOKYO and INDIANAPOLIS, Nov 04, 2007 -- In ...
Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The newer antiplatelet agent prasugrel was no better than the old standby ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback